Lv11
60 积分 2024-08-07 加入
Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma
12小时前
待确认
Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826
28天前
已关闭
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL
1个月前
已关闭
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
4个月前
已完结
Treatment of Relapsed/Refractory MCL
4个月前
已完结
Building the Future Management of Follicular Lymphoma with T-Cell-Redirecting Strategies
4个月前
已完结
The current landscape of frontline large B-cell lymphoma trials
4个月前
已完结
Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report
5个月前
已关闭
LBA58 A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG
6个月前
已关闭
Brentuximab vedotin in combination with lenalidomide and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma: Results from the phase 3 ECHELON-3 study
6个月前
已完结
皖公网安备34019202002308
